Cargando…

A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides

Gluten is a complex of proteins present in barley, wheat, rye and several varieties of oats that triggers celiac disease in genetically predisposed subjects. Gluten is notoriously difficult to digest by mammalian proteolytic enzymes and therefore, proline-rich digestion-resistant peptides contain mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno Amador, María de Lourdes, Arévalo-Rodríguez, Miguel, Durán, Encarnación Mellado, Martínez Reyes, Juan Carlos, Sousa Martín, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597064/
https://www.ncbi.nlm.nih.gov/pubmed/31246975
http://dx.doi.org/10.1371/journal.pone.0218346
_version_ 1783430540912754688
author Moreno Amador, María de Lourdes
Arévalo-Rodríguez, Miguel
Durán, Encarnación Mellado
Martínez Reyes, Juan Carlos
Sousa Martín, Carolina
author_facet Moreno Amador, María de Lourdes
Arévalo-Rodríguez, Miguel
Durán, Encarnación Mellado
Martínez Reyes, Juan Carlos
Sousa Martín, Carolina
author_sort Moreno Amador, María de Lourdes
collection PubMed
description Gluten is a complex of proteins present in barley, wheat, rye and several varieties of oats that triggers celiac disease in genetically predisposed subjects. Gluten is notoriously difficult to digest by mammalian proteolytic enzymes and therefore, proline-rich digestion-resistant peptides contain multiple immunogenic epitopes. Prolyl endopeptidases (PEP) hydrolyse internal proline residues on the carboxyl side of peptides and have been proposed for food gluten detoxification and as oral enzyme supplementation for celiacs. The aim of this study was to identify new gluten-degrading microbial enzymes with the potential to reduce gluten immunogenicity by neutralizing its antigenic epitopes. Using a gluten-degrading colony screening approach, a bacterial isolate (2RA3) displaying the highest glutenase activity was selected, characterized and its genome completely sequenced. The identification through 16S rDNA gene sequencing showed a 99,1% similarity to Chryseobacterium taeanense. Hydrolysis of gluten immunogenic peptides (GIP) was further monitored, over a 48-hour period, by colony encapsulation in gliadin-containing microspheres, followed by detection with the G12 anti-GIP monoclonal antibody. Glutenase activity was detected in the extracellular medium of 2RA3 cultures, where gel electrophoresis and gliadin zymography revealed the presence of a ~50 kDa gluten-degrading enzyme. Nano-ESI-Q-TOF of the excised active band identified 7 peptides contained in the protein product predicted for an open reading frame (ORF) in the 2RA3 genome. Based on sequence similarity to the PEP family, the new enzyme was named PEP 2RA3. The PEP 2RA3 coding sequence was PCR-amplified from C. taeanense 2RA3, cloned and expressed in Escherichia coli as a C-terminally His-tagged recombinant protein and purified by Ni-NTA affinity chromatography. The recombinant protein, with predicted molecular mass and isoelectric point of 78.95 kDa and 6.8, respectively, shows PEP activity with standard chromogenic substrates, works optimally at pH 8.0 and 30°C and remains stable at pH 6.0 and 50°C, indicating a potential use in gluten-containing food process applications. The ability of the recombinant enzyme to degrade GIP in beer into smaller peptides was confirmed.
format Online
Article
Text
id pubmed-6597064
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65970642019-07-05 A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides Moreno Amador, María de Lourdes Arévalo-Rodríguez, Miguel Durán, Encarnación Mellado Martínez Reyes, Juan Carlos Sousa Martín, Carolina PLoS One Research Article Gluten is a complex of proteins present in barley, wheat, rye and several varieties of oats that triggers celiac disease in genetically predisposed subjects. Gluten is notoriously difficult to digest by mammalian proteolytic enzymes and therefore, proline-rich digestion-resistant peptides contain multiple immunogenic epitopes. Prolyl endopeptidases (PEP) hydrolyse internal proline residues on the carboxyl side of peptides and have been proposed for food gluten detoxification and as oral enzyme supplementation for celiacs. The aim of this study was to identify new gluten-degrading microbial enzymes with the potential to reduce gluten immunogenicity by neutralizing its antigenic epitopes. Using a gluten-degrading colony screening approach, a bacterial isolate (2RA3) displaying the highest glutenase activity was selected, characterized and its genome completely sequenced. The identification through 16S rDNA gene sequencing showed a 99,1% similarity to Chryseobacterium taeanense. Hydrolysis of gluten immunogenic peptides (GIP) was further monitored, over a 48-hour period, by colony encapsulation in gliadin-containing microspheres, followed by detection with the G12 anti-GIP monoclonal antibody. Glutenase activity was detected in the extracellular medium of 2RA3 cultures, where gel electrophoresis and gliadin zymography revealed the presence of a ~50 kDa gluten-degrading enzyme. Nano-ESI-Q-TOF of the excised active band identified 7 peptides contained in the protein product predicted for an open reading frame (ORF) in the 2RA3 genome. Based on sequence similarity to the PEP family, the new enzyme was named PEP 2RA3. The PEP 2RA3 coding sequence was PCR-amplified from C. taeanense 2RA3, cloned and expressed in Escherichia coli as a C-terminally His-tagged recombinant protein and purified by Ni-NTA affinity chromatography. The recombinant protein, with predicted molecular mass and isoelectric point of 78.95 kDa and 6.8, respectively, shows PEP activity with standard chromogenic substrates, works optimally at pH 8.0 and 30°C and remains stable at pH 6.0 and 50°C, indicating a potential use in gluten-containing food process applications. The ability of the recombinant enzyme to degrade GIP in beer into smaller peptides was confirmed. Public Library of Science 2019-06-27 /pmc/articles/PMC6597064/ /pubmed/31246975 http://dx.doi.org/10.1371/journal.pone.0218346 Text en © 2019 Moreno Amador et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Moreno Amador, María de Lourdes
Arévalo-Rodríguez, Miguel
Durán, Encarnación Mellado
Martínez Reyes, Juan Carlos
Sousa Martín, Carolina
A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides
title A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides
title_full A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides
title_fullStr A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides
title_full_unstemmed A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides
title_short A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides
title_sort new microbial gluten-degrading prolyl endopeptidase: potential application in celiac disease to reduce gluten immunogenic peptides
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597064/
https://www.ncbi.nlm.nih.gov/pubmed/31246975
http://dx.doi.org/10.1371/journal.pone.0218346
work_keys_str_mv AT morenoamadormariadelourdes anewmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT arevalorodriguezmiguel anewmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT duranencarnacionmellado anewmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT martinezreyesjuancarlos anewmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT sousamartincarolina anewmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT morenoamadormariadelourdes newmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT arevalorodriguezmiguel newmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT duranencarnacionmellado newmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT martinezreyesjuancarlos newmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides
AT sousamartincarolina newmicrobialglutendegradingprolylendopeptidasepotentialapplicationinceliacdiseasetoreduceglutenimmunogenicpeptides